MedTrace Logo

Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes

NCT02553577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278

Last updated 2021-07-07

No results posted yet for this study

Summary

There has been a dramatic escalation of electronic cigarette (e-cig) use among women of childbearing age, including pregnant women. The overall goal of this study is to determine the effects of e-cigs on prenatal biomarkers and birth outcomes. It is imperative that more data about these effects be available to better inform women of childbearing age.

Conditions

  • Immune Response
  • Birth Weight
  • Gestational Age

Sponsors & Collaborators

  • Virginia Commonwealth University

    collaborator OTHER

  • Kristin Ashford

    lead OTHER

Principal Investigators

  • Kristin B Ashford, PhD · University of Kentucky

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-13
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02553577 on ClinicalTrials.gov